Though insulin capsules are still in early stages in clinical trial, the below experimental study is also done with insulin capsules: In a small, preliminary study, high-dose insulin capsules safely induced what appears to be a protective immune response in children at high risk of developing type 1 diabetes. If these findings hold true in larger studies done over longer periods of time, the treatment may prevent the development of type 1 diabetes in high-risk kids, much like allergy shots can prime the immune system not to react to harmless allergens, researchers say.
"We have introduced a relatively new paradigm, which is to actively expose the body to one of its own proteins before the body has a chance to see it as foreign and to eliminate it like a virus, something which happens in children who develop type 1 diabetes," said the study's lead author, Ezio Bonifacio, deputy director…
